Stockmarkets remain unimpressed by news of the latest vaccine
Stockmarkets went mad on news of Pfizer’s Covid-19 vaccine, but a similar update from AstraZeneca brought little more than a shrug.
Free, fast, fair
Continue reading this article and get instant access to even more investment news by registering your details below: